News & Updates

One-sixth of lesbian, gay, bisexual, transgender, queer, intersex, and other gender and sexually diverse (LGBTQI+) populations in Thailand reported a suicide attempt, while half of them had ever contemplated suicide, a study has shown.

The use of bright light therapy with gradual advance protocol in the adjunctive setting appears to be beneficial to patients with nonseasonal unipolar depression and evening chronotype, with a study showing that it rapidly induces remission in most patients.

Patients on high-dose citalopram (>20 mg) and high-dose escitalopram (>10 mg) are more likely to experience out-of-hospital cardiac arrest (OHCA) than those on sertraline, while users of high-dose mirtazapine (>30 mg) have a higher OHCA rate than those on duloxetine, a study has shown.

In patients diagnosed with opioid use disorders, those who received medication-assisted therapy (MAT) prescriptions have a higher risk of cardiac arrhythmia than those who did not, reports a study.

New drug applications approved by US FDA as of 16 - 30 June 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.